Long-term tolerability of etoricoxib in different types of NSAID-intolerant subjects

European Annals of Allergy and Clinical Immunology

Volumn 42, Issue 6, 2010, Pages 216-220

  Pagani, M ^a   Bonadonna, P ^b   Dama, A ^b   Senna, G E ^b   Vescovi, P P ^a   Antico, A ^a  

^a Ospedale Civile di Asola   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Adherence to therapy; Challenge test with etoricoxib; Nsaids hypersensitivity

Indexed keywords

ARYLACETIC ACID DERIVATIVE; CYCLOOXYGENASE 2 INHIBITOR; ETORICOXIB; NONSTEROID ANTIINFLAMMATORY AGENT; OXICAM DERIVATIVE; PARACETAMOL; PLACEBO; PYRAZOLONE DERIVATIVE; SALICYLIC ACID DERIVATIVE;

ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PROVOCATION TEST; RHINITIS; SINGLE BLIND PROCEDURE; URTICARIA;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 2 INHIBITORS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; MALE; MIDDLE AGED; PYRIDINES; SINGLE-BLIND METHOD; SULFONES;

EID: 78650244680     PISSN: 03979148     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Warner TD, Mitchell JA. Cyclooxigenase: new forms, new inhibitors and lessons from the clinic. FASEB J 2004;18:790-804.
2. Stevenson DD. Aspirin and NSAID sensitivity. Immunol Allergy Clin N Am 2004;24:491-505.
3. Szczeklik A, Sanak M, Nizankowska-Mogilnicka E, Kielbasa B. Aspirin intolerance and the cyclooxygenase-leukotriene pathways. Curr Opin Pulm Med 2004;10:51-6.
4. Kong JSW, Teuber SS, Gershwin ME. Aspirin and nonsteroidal anti-inflammatory drugs hypersensitivity. Clin Rev Allergy Immunol 2007;32:97-110.
5. Altamura Namazy J, Simon RA. Sensitivity to nonsteroidal antiinflammatory drugs. Ann Allergy Asthma Immunol 2002;89:542-50.
6. Settipane GA. Aspirin and allergic diseases: a review. Am J Med 1983;74:102-9.
7. Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 2004;328:434.
8. Erbagci Z. Multiple NSAID intolerance in chronic idiophatic urticaria is correlated with delayed, pronounced and prolonged autoreactivity. J Dermatol 2004;31:376-82.
9. Leone R, Conforti A, Venegoni M, et al. Drug-induced anaphylaxis. Case/non case study based on an Italian pharmacovigilance database. Drug Saf 2005;28:548-56.
10. Layton D, Marshall V, Boshier A, Friedmann P, Shakir S AW. Serious skin reactions and selective COX-2 inhibitors. A case series from prescription-event monitoring in England. Drug Saf 2006;29:687-96.
11. Morais Almeida M, Marinho S, Rosa S, Gaspar A, Rosado-Pinto JE. Multiple drug intolerance including etoricoxib. Allergy 2006;61:144-5.
12. Koschel D, Cardoso C, Leucht V, Hoffken G. Asthmatic reaction induced by etoricoxib in a patient with aspirin-sensitive asthma. Allergy 2008;63:1093-4.
13. Reindeau D, Percival MD, Brideau C, et al. Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2 J Pharmacol Exp Ther 2001;296:558-66.
14. Muratore L, Ventura M, Calogiuri G, et al. Tolerance to etoricoxib in 37 patients with urticaria and angioedema induced by nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol 2007;98:168-71.
15. Sanchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A. Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema. Anna Allergy Asthma Immunol 2005;95:154-8.
16. Viola M, Quaratino D, Gaeta F, Caruso C, Valluzzi R, Romano A. Etoricoxib tolerability in patients with hypersensitivity to nonsteroidal anti-inflammatory drugs. Int Arch Allergy Immunol 2007;143:103-8.
17. Nettis E, Colanardi MC, Ferranini A, Vacca A, Tursi A. Shortterm tolerability of etoricoxib in patients with cutaneous hypersensitivity reactions to nonsteroidal anti-inflammatory drugs. Ann Allergy Immunol 2005;95:438-42.
18. Asero R. Etoricoxib challenge in patients with chronic urticaria with NSAID intolerance. Clin Exp Dermatol 2007;32:661-3.
19. Nettis E, Colanardi MC, Ferrannini A, Tursi A. Short term and long term tolerability of rofecoxib in patients with prior reactions to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol 2005;94:29-33.
20. Di Leo E, Aloia AM, Nettis E, et al. Long-term tolerability of etoricoxib in patients with previous reactions to non-steroidal anti-inflammatory drugs. Int J Immunopathol Pharmacol 2009;22:1131-4.